An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis
- 1 October 2012
- journal article
- research article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 74 (2), 207-209
- https://doi.org/10.1016/j.diagmicrobio.2012.06.013
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosisThe International Journal of Tuberculosis and Lung Disease, 2012
- Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?The International Journal of Tuberculosis and Lung Disease, 2011
- Silent Mutation in rpoB Detected from Clinical Samples with Rifampin-Susceptible Mycobacterium tuberculosisJournal of Clinical Microbiology, 2011
- Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective StudyPLoS Medicine, 2011
- Comparison of Xpert MTB/RIF with Other Nucleic Acid Technologies for Diagnosing Pulmonary Tuberculosis in a High HIV Prevalence Setting: A Prospective StudyPLoS Medicine, 2011
- Isolation of Mycobacterium tuberculosis Strains with a Silent Mutation in rpoB Leading to Potential Misassignment of Resistance CategoryJournal of Clinical Microbiology, 2011
- Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation studyThe Lancet, 2011
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceThe New England Journal of Medicine, 2010
- Detection of rifampicin-resistance mutations in Mycobacterium tuberculosisThe Lancet, 1993